This study first verifies the effect and mechanism of a natural supplement GSP reversing MDR by interacting P-gp, suggesting that GSP may be used in combination with conventional P-gp substrate chemotherapeutic drugs to overcome MDR in ovarian cancer patients, providing a new use of such natural supplements as a chemo-sensitizer. The gene discussed is PGP; the disease is ovarian cancer.